The estimated Net Worth of Todd W Garner is at least $5.26 Million dollars as of 13 March 2023. Mr Garner owns over 30,000 units of Conmed stock worth over $2,282,908 and over the last 7 years he sold CNMD stock worth over $2,153,884. In addition, he makes $826,504 as Exec. VP & CFO at Conmed.
Mr has made over 18 trades of the Conmed stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 1,355 units of CNMD stock worth $151,760 on 16 August 2023.
The largest trade he's ever made was exercising 30,000 units of Conmed stock on 13 March 2023 worth over $1,518,300. On average, Mr trades about 2,260 units every 56 days since 2018. As of 13 March 2023 he still owns at least 31,115 units of Conmed stock.
You can see the complete history of Mr Garner stock trades at the bottom of the page.
Todd W. Garner is the Exec. VP & CFO at Conmed.
As the Exec. VP & CFO of Conmed, the total compensation of Mr Garner at Conmed is $826,504. There are 2 executives at Conmed getting paid more, with Curt R. Hartman having the highest compensation of $1,787,620.
Mr Garner is 52, he's been the Exec. VP & CFO of Conmed since . There are 5 older and 3 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.
Todd's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti, and Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
Conmed executives and other stock owners filed with the SEC include: